Influence of coexisting Hashimoto thyroiditis on the postoperative residual thyroid tissue ablation success after the first dose of 3.7 GBq of iodine-131 in patients with differentiated thyroid carcinoma

被引：0
|
作者：
Rajic, M. P. [1 ]
Vlajkovic, M. [1 ]
Ilic, S. [1 ]
Stevic, M. [1 ]
Misic, I. [1 ]
Kojic, M. [1 ]
机构：
[1] Univ Nis, Sch Med, Nish, Serbia
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0823
引用
收藏
页码：S781 / S782
页数：2
相关论文
共 50 条
  • [31] A randomized equivalence trial to determine the optimum dose of iodine-131 for remnant ablation in differentiated thyroid cancer
    Bal, Chandrasekhar
    Chandra, Prem
    Kumar, Ajay
    Dwivedi, Sadanand
    NUCLEAR MEDICINE COMMUNICATIONS, 2012, 33 (10) : 1039 - 1047
  • [32] Low versus high radioiodine dose in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma: a large randomized clinical trial
    Fallahi, Babak
    Beiki, Davood
    Takavar, Abbas
    Fard-Esfahani, Armaghan
    Gilani, Kianoush Ansari
    Saghari, Mohsen
    Eftekhari, Mohammad
    NUCLEAR MEDICINE COMMUNICATIONS, 2012, 33 (03) : 275 - 282
  • [33] Evaluation of iodine-131 therapy for differentiated thyroid carcinoma patients with elevated thyroglobulin and negative iodine-131 whole body scan.
    Tian, R
    Qin, SW
    Kuang, RA
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 334P - 334P
  • [34] Differentiated Thyroid Carcinoma After Iodine-131 Metaiodobenzylguanidine Treatment for Neuroblastoma: Assessment of Causality Response
    van Santen, Hanneke M.
    Tytgat, Godelieve A. M.
    de Wetering, Marianne D. van
    van Eck-Smit, Berthe L. F.
    Hopman, Saskia M. J.
    van der Steeg, Alida F.
    van Dijkum, Els J. M. Nieveen
    van Trotsenburg, A. S. Paul
    THYROID, 2013, 23 (02) : 249 - 249
  • [35] To Ablate or Not to Ablate: Issues and Evidence Involved in 131I Ablation of Residual Thyroid Tissue in Patients with Differentiated Thyroid Carcinoma
    Goldsmith, Stanley J.
    SEMINARS IN NUCLEAR MEDICINE, 2011, 41 (02) : 96 - 104
  • [36] Required therapeutic dose of 131I for thyroid ablation after surgery for differentiated thyroid carcinoma
    Yaneva, M.
    Botushanova, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S399 - S399
  • [37] Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid
    Barrington, S.F.
    Kettle, A.G.
    O'Doherty, M.J.
    Wells, C.P.
    Somer, E.J.R.
    Coakley, A.J.
    European Journal of Nuclear Medicine and Molecular Imaging, 1996, 23 (02): : 123 - 130
  • [38] Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid
    Barrington, SF
    Kettle, AG
    ODoherty, MJ
    Wells, CP
    Somer, EJR
    Coakley, AJ
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1996, 23 (02): : 123 - 130
  • [39] Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid
    S. F. Barrington
    A. G. Kettle
    M. J. O’Doherty
    C. P. Wells
    E. J. R. Somer
    A. J. Coakley
    European Journal of Nuclear Medicine, 1997, 24 : 1545 - 1545
  • [40] Persistent disease in patients with papillary thyroid carcinoma and lymph node metastases after surgery and iodine-131 ablation
    Verburg, Frederik A.
    de Keizer, Bart
    Lam, Marnix G. E. H.
    de Klerk, J. M. H.
    Lips, Cornelis J. M.
    Borel-rinkes, Inne H. M.
    van Isselt, Johannes W.
    WORLD JOURNAL OF SURGERY, 2007, 31 (12) : 2309 - 2314
12345